 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Klein Lawrence Otto
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-07-10 Sale | 2019-07-12 4:13 pm | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 20,000 | $50.02 | $1,000,353 | 20,000 (Direct) | View |
| 2020-05-11 Sale | 2020-05-13 4:38 pm | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 25,000 | $60.4 | $1,509,971 | 20,000 (Direct) | View |
| 2020-06-24 Sale | 2020-06-26 4:33 pm | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 70,000 | $75.88 | $5,311,564 | 20,000 (Direct) | View |
| 2021-01-15 Sale | 2021-01-20 6:07 pm | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 25,000 | $215.2 | $5,379,940 | 20,000 (Direct) | View |
| 2021-03-23 Sale | 2021-03-25 5:39 pm | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 100,000 | $128.05 | $12,805,240 | 1,050 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-01-02 Option Award | 2019-01-03 4:32 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 20,000 | $29.87 | 20,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-03 4:32 pm | N/A 2029-01-01 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-03-05 Option Award | 2019-03-07 4:17 pm | N/A 2029-03-05 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 45,000 | $0 | 45,000 (Direct) | View |
| 2019-07-10 Exercise | 2019-07-12 4:13 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 11,579 | $5.86 | 31,579 (Direct) | View |
| 2019-07-10 Exercise | 2019-07-12 4:13 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 8,421 | $5.86 | 28,421 (Direct) | View |
| 2019-07-10 Exercise | 2019-07-12 4:13 pm | N/A 2026-03-01 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 11,579 | $0 | 72,087 (Direct) | View |
| 2019-07-10 Exercise | 2019-07-12 4:13 pm | N/A 2026-03-01 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 8,421 | $0 | 63,666 (Direct) | View |
| 2019-09-10 Option Award | 2019-09-12 4:32 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 10,000 | $0 | 30,000 (Direct) | View |
| 2019-12-03 Option Award | 2019-12-05 4:05 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto Chief Business Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2020-03-10 Option Award | 2020-03-12 4:10 pm | N/A 2030-03-10 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-03-10 Option Award | 2020-03-12 4:10 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 13,750 | $0 | 13,750 (Direct) | View |
| 2020-05-11 Exercise | 2020-05-13 4:38 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 25,000 | $5.86 | 45,000 (Direct) | View |
| 2020-05-11 Exercise | 2020-05-13 4:38 pm | N/A 2026-03-01 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 25,000 | $0 | 38,666 (Direct) | View |
| 2020-06-24 Exercise | 2020-06-26 4:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 38,666 | $5.86 | 58,666 (Direct) | View |
| 2020-06-24 Exercise | 2020-06-26 4:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 26,422 | $12.57 | 46,422 (Direct) | View |
| 2020-06-24 Exercise | 2020-06-26 4:33 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 4,912 | $12.57 | 24,912 (Direct) | View |
| 2020-06-24 Exercise | 2020-06-26 4:33 pm | N/A 2026-03-01 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 38,666 | $0 | 0 (Direct) | View |
| 2020-06-24 Exercise | 2020-06-26 4:33 pm | N/A 2026-07-14 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 26,422 | $0 | 13,578 (Direct) | View |
| 2020-06-24 Exercise | 2020-06-26 4:33 pm | N/A 2026-07-14 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 4,912 | $0 | 8,666 (Direct) | View |
| 2020-07-31 Conversion | 2020-09-23 7:04 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director | 10,725 | $0 | 10,725 (Direct) | View |
| 2020-07-31 Option Award | 2020-09-23 7:04 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director | 11,156 | $0 | 11,156 (Direct) | View |
| 2020-07-31 Option Award | 2020-09-23 7:04 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director | 14,444 | $0 | 14,444 (Direct) | View |
| 2020-07-31 Purchase | 2020-09-23 7:04 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director | 35,574 | $2.811 | 35,574 (Direct) | View |
| 2020-07-31 Conversion | 2020-09-23 7:04 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director | 35,574 | $0 | 0 (Direct) | View |
| 2020-10-05 Option Award | 2020-10-06 5:38 pm | N/A 2030-10-05 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 16,666 | $0 | 16,666 (Direct) | View |
| 2021-01-02 Tax Withholding | 2021-01-04 4:12 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 9,392 | $153.11 | 10,608 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 6:07 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 8,666 | $12.57 | 28,666 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 6:07 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 16,344 | $14.43 | 36,334 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 6:07 pm | N/A 2026-07-14 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 8,666 | $0 | 0 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 6:07 pm | N/A 2027-06-14 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 16,334 | $0 | 14,666 (Direct) | View |
| 2021-01-15 Exercise | 2021-03-12 5:37 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 16,334 | $14.43 | 26,942 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 5:47 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 4,583 | $0 | 15,191 (Direct) | View |
| 2021-03-10 Tax Withholding | 2021-03-12 5:47 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 2,141 | $124.15 | 13,050 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 5:47 pm | N/A 2031-03-11 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 33,334 | $0 | 33,334 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 5:47 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $0 | 12,000 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $44.67 | 25,050 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 22,000 | $51.49 | 47,050 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 10,000 | $29.87 | 57,050 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 20,000 | $40.87 | 77,050 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $14.43 | 89,050 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $17.66 | 101,050 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A 2027-06-14 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $0 | 2,666 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A 2027-11-14 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $0 | 3,000 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A 2028-03-06 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 22,000 | $0 | 38,000 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A 2029-01-01 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A 2029-03-05 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 20,000 | $0 | 25,000 (Direct) | View |
| 2021-03-23 Exercise | 2021-03-25 5:39 pm | N/A 2030-03-10 | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 12,000 | $0 | 43,000 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-27 8:38 pm | N/A 2031-05-25 | Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director | 19,596 | $0 | 19,596 (Direct) | View |
| 2021-09-10 Exercise | 2021-09-14 9:44 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 10,000 | $0 | 11,050 (Direct) | View |
| 2021-09-10 Tax Withholding | 2021-09-14 9:44 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 4,207 | $117.86 | 6,843 (Direct) | View |
| 2021-09-10 Tax Withholding | 2021-09-14 9:44 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto COO | 10,000 | $0 | 0 (Direct) | View |